|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net of allowance of $4 and $4 | |||||||||||||
| Inventories, net | |||||||||||||
| Other receivables | |||||||||||||
| Prepaid expenses and other | |||||||||||||
| Assets held for sale (Note 4) | |||||||||||||
| Total current assets | |||||||||||||
| Non-current assets: | |||||||||||||
| Property and equipment, net of accumulated depreciation of $148 and $135 | |||||||||||||
| Property and equipment, net (Note 5) | |||||||||||||
| Operating lease right-of-use assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Other intangibles, net of accumulated amortization of $503 and $451 | |||||||||||||
| Investments and other | |||||||||||||
| Investments | |||||||||||||
| Other non-current assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES, MEZZANINE EQUITY, AND SHAREHOLDERS' EQUITY | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Current maturities of long-term debt and other borrowings | |||||||||||||
| Accrued payroll and related liabilities | |||||||||||||
| Accrued taxes | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Liabilities held for sale (Note 4) | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-current liabilities: | |||||||||||||
| Long-term debt and other borrowings, net (Note 8) | |||||||||||||
| Long-term debt and other borrowings, net | |||||||||||||
| Deferred income taxes | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Mezzanine equity: | |||||||||||||
| Redeemable non-controlling interests | |||||||||||||
| Redeemable Series A convertible preferred stock, $0.01 par value per share, $1,000 per share liquidation preference, 250,000 shares authorized, and 90,632 outstanding as of September 30, 2020 (Note 12) | |||||||||||||
| Shareholders' equity: | |||||||||||||
| Common stock | |||||||||||||
| Net former parent investment | |||||||||||||
| Accumulated other comprehensive loss (Note 8) | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total shareholders’ equity | |||||||||||||
| Total liabilities, mezzanine equity, and shareholders’ equity | |||||||||||||
| Common stock, shares authorized (in shares) | |||||||||||||
| Common stock, shares outstanding (in shares) | |||||||||||||
| Common stock, shares issued (in shares) |
Loading...
